RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A Stock
Shares outstanding
525,302,736
Total 13F shares
304,544,141
Share change
+39,617,419
Total reported value
$2,058,776,356
Put/Call ratio
129%
Price per share
$6.76
Number of holders
310
Value change
+$268,240,445
Number of buys
177
Number of sells
93

Security key

75629V104

Report period

Q4 2024

Institutions

310

Top holders

10

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAILLIE GIFFORD & CO
13F 13D/G
Company
6.5%
from 13D/G
25,239,870
$166,330,743 30 Sep 2024
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
2%
from 13D/G
15,384,615
$101,384,613 30 Sep 2024
ARK Investment Management LLC
13F
Company
6.2%
32,769,186
$215,948,936 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
4.6%
24,272,798
$159,957,739 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
3.9%
20,742,797
$136,695,032 30 Sep 2024
13F
Mubadala Investment Co PJSC
3/4/5 13F
10%+ Owner · Company
2.5%
from 13F
12,985,927
$137,333,970 02 Mar 2023
STATE STREET CORP
13F
Company
2.5%
12,870,272
$84,815,092 30 Sep 2024
13F
Kinnevik AB (publ)
13F
Company
2.3%
11,905,668
$78,458,352 30 Sep 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
1.9%
9,766,728
$64,362,738 30 Sep 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
1.8%
9,694,778
$63,888,587 30 Sep 2024
13F
MIC Capital Management UK LLP
13F
Company
1.6%
8,451,758
$55,697,086 30 Sep 2024
13F
FMR LLC
13F
Company
1.6%
8,363,530
$55,115,661 30 Sep 2024
13F
NVIDIA CORP
13F
Company
1.5%
7,706,363
$50,784,932 30 Sep 2024
13F
Data Collective IV GP, LLC
13F
Company
1.1%
5,941,120
$39,151,981 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
5,431,911
$35,803,412 30 Sep 2024
13F
DCVC Opportunity Fund II GP, LLC
13F
Company
0.75%
3,951,141
$26,038,019 30 Sep 2024
13F
Lingotto Investment Management LLP
13F
Company
0.7%
3,675,077
$24,218,757 30 Sep 2024
13F
NORGES BANK
13F
Company
0.68%
3,572,556
$23,543,144 30 Sep 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.44%
2,315,000
$15,255,850 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.41%
2,140,750
$14,107,543 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.39%
2,022,625
$13,329,098 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.37%
1,940,680
$12,789,081 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.36%
1,877,201
$12,370,764 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.33%
1,717,779
$11,324,049 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
1,597,298
$10,526,194 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.29%
1,539,704
$10,146,649 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.22%
1,176,191
$7,751,099 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.22%
1,165,425
$7,680,153 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.21%
1,123,785
$7,405,742 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.2%
1,069,599
$7,048,657 30 Sep 2024
13F
Liontrust Investment Partners LLP
13F
Company
0.19%
990,000
$7,425,000 30 Sep 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.19%
973,583
$6,415,912 30 Sep 2024
13F
Comprehensive Financial Management LLC
13F
Company
0.18%
941,895
$6,207,090 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.18%
926,118
$6,103,118 30 Sep 2024
13F
UBS Group AG
13F
Company
0.15%
799,860
$5,271,077 30 Sep 2024
13F
Vestmark Advisory Solutions, Inc.
13F
Company
0.14%
732,933
$4,830,029 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.13%
697,432
$4,596,079 30 Sep 2024
13F
Cercano Management LLC
13F
Company
0.13%
685,018
$4,514,269 30 Sep 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.13%
675,791
$4,453,463 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.13%
671,319
$4,423,992 30 Sep 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.12%
642,308
$4,232,000 30 Sep 2024
13F
TWINBEECH CAPITAL LP
13F
Company
0.1%
535,079
$3,526,171 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.09%
489,900
$3,228,441 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.08%
408,986
$2,695,217 30 Sep 2024
13F
Bellevue Group AG
13F
Company
0.07%
392,881
$2,589,086 30 Sep 2024
13F
LPL Financial LLC
13F
Company
0.07%
360,438
$2,375,286 30 Sep 2024
13F
Swiss National Bank
13F
Company
0.07%
357,100
$2,353,289 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
310,468
$2,045,969 30 Sep 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.05%
284,713
$1,876,000 30 Sep 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.05%
281,467
$1,854,850 30 Sep 2024
13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q4 2024

As of 31 Dec 2024, RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by 310 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 304,544,141 shares. The largest 10 holders included VANGUARD GROUP INC, ARK Investment Management LLC, BAILLIE GIFFORD & CO, BlackRock, Inc., SOFTBANK GROUP CORP., Mubadala Investment Co PJSC, STATE STREET CORP, Kinnevik AB (publ), Novo Holdings A/S, and MIC Capital Management UK LLP. This page lists 314 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
262
Q4 2024 holders
310
Holder diff
48
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .